Transcenta Holding Limited 創勝集團醫藥有限公司

Pay for financial year ended 2021-12-31

Name Last
position
Fees Salary &
benefits
Bonus Retire Share-
based
Total

CNY '000

Directors

1 Bao, Jun (Impact Therapeutics) 包駿 INED 50 50
2 Qian, Xueming 錢雪明 CEO 771 1,301 1,880 136 1,086 5,174
3 Shi, Michael Ming 石明 ED 2,925 1,495 189 4,609
4 Tang, Jiasong 唐稼松 INED 50 50
5 Zhang, Zhihua (1982) 張志華 INED 50 50
6 Zhao, Jonathan Yining 趙奕寧 NED, Ch 646 519 176 20,735 22,076
7 Zhu, Albert Da 朱達 ED 2,021 1,040 121 943 4,125
Total 1,567 6,766 4,591 446 22,764 36,134

Main board pay history

Click on the year-end to see the pay details.

CNY'000

Year-end Fees Salary &
benefits
Bonus Retire Share-
based
Total
2023-12-31 3,252 4,759 676 375 15,338 24,400 Report
2022-12-31 2,878 7,847 3,265 593 1,533 16,116 Report
2021-12-31 1,567 6,766 4,591 446 22,764 36,134 Report
Total 7,697 19,372 8,532 1,414 39,635 76,650

Want to see more years here? volunteer to be a Webb-site editor and add the data from annual reports!


Sign up for our free newsletter

Recommend Webb-site to a friend

Copyright & disclaimer, Privacy policy

Back to top